Hematology
1879, Germany — Paul Ehrlich's publication describing eosinophil identification via differential staining
Eosinophilia, the elevation of a particular type of white blood cell in circulating blood, became a recognized hematological phenomenon only after the refinement of microscopic blood analysis in the nineteenth century. Earlier medical traditions had no means of isolating this cell population and instead interpreted associated conditions through humoral or constitutional frameworks. The history of eosinophilia was therefore inseparable from the broader history of hematology and parasitology, fields that matured together in the late 1800s.
Historical Narrative
Before the advent of the compound microscope and the development of blood-staining techniques, no physician possessed the technical means to identify eosinophils as a discrete cellular category. Ancient and medieval medical traditions described fevers, wasting, and skin eruptions that may in some cases have reflected conditions associated with elevated eosinophil counts, but these were interpreted entirely through the lens of humoralism. Galenic medicine attributed such presentations to imbalances of phlegm, blood, yellow bile, or black bile, and the cellular composition of blood remained entirely beyond the conceptual reach of practitioners until the early modern period.
The foundational work of identifying blood cells as discrete entities began in earnest in the seventeenth century with the microscopic observations of Antonie van Leeuwenhoek, who described various corpuscles in blood without yet possessing the means to classify them by type. For nearly two more centuries, blood examination remained largely descriptive and qualitative, unable to distinguish among white cell populations.
The critical breakthrough came in 1879, when the German physiologist Paul Ehrlich published his method for differentially staining blood cells using aniline dyes. Ehrlich discovered that certain granular leukocytes exhibited a striking affinity for acidic dyes, particularly eosin, a rose-red compound, and he named these cells eosinophils accordingly. His staining methodology allowed for the first systematic differentiation of white blood cell types and made it possible to count and compare cell populations across patients. Ehrlich's contributions to hematology were foundational, ultimately contributing to his Nobel Prize in Physiology or Medicine in 1908.
Almost immediately after Ehrlich's characterization of eosinophils, clinicians began documenting their elevation in association with certain diseases. James Hardy and colleagues in England, along with continental European researchers, noted elevated eosinophil counts in patients harboring parasitic worm infections, a connection that proved remarkably consistent and that would anchor much of the subsequent research into eosinophil function. By the 1890s, the clinical association between helminthic parasites and eosinophilia was sufficiently established that some physicians began using blood examination as an indirect indicator of parasitic infestation.
In the early twentieth century, researchers began investigating eosinophilia in the context of allergic and hypersensitivity phenomena. The emerging field of immunology, shaped by figures including Charles Richet and Paul Portier, whose anaphylaxis experiments won Richet the Nobel Prize in 1913, provided a theoretical backdrop for understanding eosinophils as participants in the body's reactivity to foreign substances. Clinicians observed elevated counts in patients with asthma, hay fever, and urticaria, though the mechanistic explanation for this association remained elusive for decades.
Throughout the mid-twentieth century, hematologists and immunologists worked to characterize eosinophil biology more precisely. Wilhelm Löffler, the Swiss physician, described a transient pulmonary infiltration accompanied by peripheral eosinophilia in the 1930s, a syndrome that bore his name and that drew attention to the range of conditions in which eosinophilia could manifest. Löffler's clinical observations stimulated further investigation into cardiac, pulmonary, and systemic manifestations associated with sustained elevated eosinophil counts.
By the latter half of the twentieth century, advances in immunology and cell biology allowed researchers to identify interleukins and other signaling molecules responsible for regulating eosinophil production and survival, situating eosinophilia within a broader molecular framework and transforming a century of clinical observation into biochemical understanding.
Key Historical Figures
Historical narrative only — this page describes how Eosinophilia was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.